Related Experiment Video

Updated: Jun 3, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Novel molecular targets for prevention of obesity and osteoporosis

Srujana Rayalam1, Jeong-Yeh Yang, Mary Anne Della-Fera

  • 1Department of Animal and Dairy Science, University of Georgia, Athens, GA 30602, USA.

The Journal of Nutritional Biochemistry
|March 25, 2011
PubMed

Insights

Obesity and osteoporosis are linked, with few treatments available. Combining phytochemicals may offer a more effective approach to treat these complex conditions by targeting multiple pathways simultaneously.

Area of Science:

  • Biomedical Science
  • Metabolic Disorders
  • Bone Health

Background:

  • Obesity and osteoporosis are increasingly prevalent, complex diseases with limited treatment options.
  • Pharmaceuticals have adverse effects, leading to increased use of herbal remedies.
  • Single-target therapies (monotherapy) have shown limited success for these multifactorial conditions.

Purpose of the Study:

  • To explore the potential of phytochemical combinations as a therapeutic strategy for obesity and osteoporosis.
  • To investigate if targeting multiple cell-signaling pathways with combined phytochemicals is more effective than single compounds.

Main Methods:

  • Review of epidemiological studies and basic research on obesity and osteoporosis.
  • Analysis of emerging evidence on the efficacy of phytochemical combinations in decreasing adipogenesis and promoting bone formation.

Main Results:

  • Emerging evidence suggests specific phytochemical combinations are more effective than single compounds.
  • Combined phytochemicals show potential in reducing fat cell formation (adipogenesis) and enhancing bone formation.

Conclusions:

  • Phytochemical combinations offer a promising therapeutic avenue for obesity and osteoporosis.
  • Simultaneously targeting multiple dysfunctional pathways with phytochemicals may be an ideal strategy for prevention and treatment.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...